| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.088 | 27.271 | 37.773 | 75.738 | 91.069 | 100.060 | 86.811 | 94.490 | 121.235 | 135.008 |
| Total Income - EUR | 22.089 | 27.272 | 37.774 | 75.739 | 91.070 | 100.063 | 86.812 | 94.699 | 130.266 | 135.014 |
| Total Expenses - EUR | 17.905 | 18.645 | 19.920 | 40.064 | 44.691 | 47.341 | 39.870 | 44.968 | 49.723 | 55.742 |
| Gross Profit/Loss - EUR | 4.183 | 8.626 | 17.854 | 35.675 | 46.379 | 52.722 | 46.943 | 49.732 | 80.543 | 79.272 |
| Net Profit/Loss - EUR | 3.521 | 8.354 | 14.904 | 34.917 | 45.468 | 51.786 | 46.075 | 48.787 | 79.241 | 75.221 |
| Employees | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Acrivopol Alexandru Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 20.485 | 82.428 | 80.960 | 92.922 | 83.522 | 72.621 | 61.014 | 61.854 | 74.990 | 66.118 |
| Current Assets | 6.382 | 4.987 | 7.363 | 13.381 | 18.135 | 24.959 | 18.755 | 44.557 | 25.379 | 17.837 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.987 | 2.163 | 4.010 | 5.863 | 7.634 | 8.189 | 7.610 | 35.580 | 18.180 | 2.149 |
| Cash | 4.395 | 2.824 | 3.353 | 7.518 | 10.501 | 16.770 | 11.145 | 8.977 | 7.199 | 15.688 |
| Shareholders Funds | 2.335 | 8.407 | 18.560 | 48.292 | 88.824 | 92.090 | 46.123 | 48.835 | 97.860 | 75.270 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 24.532 | 79.008 | 69.764 | 58.011 | 12.833 | 5.491 | 33.646 | 57.576 | 2.509 | 8.685 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Acrivopol Alexandru Med Srl